Detection of Ureaplasma Biovars and Subtyping of Ureaplasma parvum among Women Referring to a University Hospital in Morocco.

Q2 Medicine
Infectious Diseases in Obstetrics and Gynecology Pub Date : 2020-06-08 eCollection Date: 2020-01-01 DOI:10.1155/2020/7286820
Safae Karim, Chahrazed Bouchikhi, Abdelaziz Banani, Hinde E L Fatemi, Tiatou Souho, Sanaa Erraghay, Bahia Bennani
{"title":"Detection of <i>Ureaplasma</i> Biovars and Subtyping of <i>Ureaplasma parvum</i> among Women Referring to a University Hospital in Morocco.","authors":"Safae Karim,&nbsp;Chahrazed Bouchikhi,&nbsp;Abdelaziz Banani,&nbsp;Hinde E L Fatemi,&nbsp;Tiatou Souho,&nbsp;Sanaa Erraghay,&nbsp;Bahia Bennani","doi":"10.1155/2020/7286820","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to determine the prevalence of <i>Ureaplasma</i> biovars and <i>Ureaplasma parvum</i> (<i>U. parvum</i>) serovars, their associated risk factors, and genital STI-related symptoms.</p><p><strong>Methods: </strong>DNA obtained from cervical samples of 1053 women attending the department of Obstetrics and Gynecology and the laboratory of pathological anatomy of Hassan II university hospital of Fez, Morocco, was used to detect <i>Ureaplasma</i> biovars (<i>U. urealyticum</i> and <i>U. parvum</i>) and to subtype <i>U. parvum</i> by polymerase chain reaction (PCR).</p><p><strong>Results: </strong>Of the 1053 women examined, 25.4% (268/1053) were <i>Ureaplasma</i> positives. The rates of <i>U. urealyticum</i> and <i>U. parvum</i> were 12.1% (128/1053) and 7% (74/1053), respectively, and the copresence of these biovars was noted in 6.3% (66/1053) cases. The <i>U. parvum</i> subtyping revealed a predominance of the serovar 3/14 (61.4%). The association of demographics variables with <i>Ureaplasma</i> biovars was studied and shows that the age (\"<30\" years) seems to be a risk factor of <i>Ureaplasma</i> spp. and <i>U. urealyticum</i> carriage (OR 1.729, 95% CI [1.113-2.687] and OR 1.848, 95% CI [1.026-3.330], respectively). There was no difference in the prevalence of <i>Ureaplasma</i> type regarding symptoms. However, a significant association was found between <i>U. parvum</i> serovar 1 and infertility (<i>P</i> = 0.011).</p><p><strong>Conclusion: </strong>This first study conducted in Morocco provides an idea on <i>Ureaplasma</i> biovars and <i>U. parvum</i> serovars circulating in this region, their associated risk factors, and genital STI-related symptoms. Therefore, further studies are required to clarify and confirm the pathogenic role of these <i>Ureaplasma</i> species.</p>","PeriodicalId":13546,"journal":{"name":"Infectious Diseases in Obstetrics and Gynecology","volume":"2020 ","pages":"7286820"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/7286820","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious Diseases in Obstetrics and Gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2020/7286820","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Objectives: The aim of this study was to determine the prevalence of Ureaplasma biovars and Ureaplasma parvum (U. parvum) serovars, their associated risk factors, and genital STI-related symptoms.

Methods: DNA obtained from cervical samples of 1053 women attending the department of Obstetrics and Gynecology and the laboratory of pathological anatomy of Hassan II university hospital of Fez, Morocco, was used to detect Ureaplasma biovars (U. urealyticum and U. parvum) and to subtype U. parvum by polymerase chain reaction (PCR).

Results: Of the 1053 women examined, 25.4% (268/1053) were Ureaplasma positives. The rates of U. urealyticum and U. parvum were 12.1% (128/1053) and 7% (74/1053), respectively, and the copresence of these biovars was noted in 6.3% (66/1053) cases. The U. parvum subtyping revealed a predominance of the serovar 3/14 (61.4%). The association of demographics variables with Ureaplasma biovars was studied and shows that the age ("<30" years) seems to be a risk factor of Ureaplasma spp. and U. urealyticum carriage (OR 1.729, 95% CI [1.113-2.687] and OR 1.848, 95% CI [1.026-3.330], respectively). There was no difference in the prevalence of Ureaplasma type regarding symptoms. However, a significant association was found between U. parvum serovar 1 and infertility (P = 0.011).

Conclusion: This first study conducted in Morocco provides an idea on Ureaplasma biovars and U. parvum serovars circulating in this region, their associated risk factors, and genital STI-related symptoms. Therefore, further studies are required to clarify and confirm the pathogenic role of these Ureaplasma species.

Abstract Image

Abstract Image

摩洛哥某大学医院妇女细小支原体生物变异检测及分型分析
目的:本研究的目的是确定脲原体生物变体和细小脲原体血清变体的流行情况、它们的相关危险因素和生殖器性传播感染相关症状。方法:采用摩洛哥非斯哈桑二世大学医院妇产科及病理解剖实验室1053例妇女宫颈标本DNA检测解脲脲原体生物变异(U. unrealyticum和U. parvum),并采用聚合酶链式反应(PCR)对U. parvum进行分型。结果:在1053名妇女中,25.4%(268/1053)为脲原体阳性。解脲脲菌和细小菌的检出率分别为12.1%(128/1053)和7%(74/1053),其中6.3%(66/1053)的病例中存在解脲脲和细小菌。小u型以血清型3/14为主(61.4%)。研究了人口统计学变量与脲原体生物变异的关系,结果表明年龄(脲原体和解脲原体携带率分别为OR 1.729, 95% CI[1.113-2.687]和OR 1.848, 95% CI[1.026-3.330])。在症状方面,脲原体型的患病率没有差异。然而,发现幼链球菌血清型1与不孕之间存在显著关联(P = 0.011)。结论:在摩洛哥进行的这项首次研究提供了在该地区流行的脲原体生物变体和细小乌原体血清变体及其相关危险因素和生殖器性传播感染相关症状的信息。因此,需要进一步的研究来阐明和确认这些脲原体的致病作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infectious Diseases in Obstetrics and Gynecology
Infectious Diseases in Obstetrics and Gynecology Medicine-Obstetrics and Gynecology
CiteScore
3.80
自引率
0.00%
发文量
17
审稿时长
12 weeks
期刊介绍: Infectious Diseases in Obstetrics and Gynecology aims to disseminate new and important information to clinicians and other health care providers, scientists, and researchers involved in the study or treatment of infectious diseases, especially those affecting the female patient. Its ultimate aim is to advance knowledge and encourage research, thereby improving the prevention or diagnosis and treatment of patients affected by such diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信